Qsemble Capital Management LP acquired a new position in Moelis & Company (NYSE:MC – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 3,079 shares of the asset manager’s stock, valued at approximately $211,000.
Several other large investors also recently modified their holdings of MC. Wealth Enhancement Advisory Services LLC grew its holdings in Moelis & Company by 51.8% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 135,399 shares of the asset manager’s stock valued at $7,699,000 after purchasing an additional 46,226 shares during the period. Sei Investments Co. grew its holdings in Moelis & Company by 18.2% during the second quarter. Sei Investments Co. now owns 305,871 shares of the asset manager’s stock valued at $17,392,000 after purchasing an additional 47,176 shares during the period. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in Moelis & Company during the third quarter valued at about $3,433,000. XTX Topco Ltd grew its holdings in Moelis & Company by 274.4% during the second quarter. XTX Topco Ltd now owns 16,524 shares of the asset manager’s stock valued at $940,000 after purchasing an additional 12,110 shares during the period. Finally, Natixis Advisors LLC grew its holdings in Moelis & Company by 13.7% during the third quarter. Natixis Advisors LLC now owns 804,860 shares of the asset manager’s stock valued at $55,141,000 after purchasing an additional 96,720 shares during the period. Institutional investors own 91.53% of the company’s stock.
Wall Street Analysts Forecast Growth
MC has been the subject of several recent research reports. UBS Group boosted their price target on Moelis & Company from $54.00 to $60.00 and gave the company a “sell” rating in a report on Tuesday, October 8th. Wells Fargo & Company initiated coverage on Moelis & Company in a research note on Thursday, September 12th. They issued an “equal weight” rating and a $70.00 price objective for the company. Finally, Morgan Stanley dropped their price objective on Moelis & Company from $67.00 to $66.00 and set an “underweight” rating for the company in a research note on Thursday, October 24th. Two investment analysts have rated the stock with a sell rating and six have issued a hold rating to the company’s stock. According to MarketBeat, Moelis & Company currently has a consensus rating of “Hold” and a consensus target price of $60.83.
Moelis & Company Stock Down 1.4 %
NYSE MC opened at $75.85 on Friday. The firm has a market cap of $5.68 billion, a price-to-earnings ratio of 143.11 and a beta of 1.33. The business has a 50-day moving average price of $71.04 and a 200-day moving average price of $64.21. Moelis & Company has a twelve month low of $45.45 and a twelve month high of $81.60.
Moelis & Company (NYSE:MC – Get Free Report) last announced its quarterly earnings results on Wednesday, October 23rd. The asset manager reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $0.02. Moelis & Company had a return on equity of 12.15% and a net margin of 4.22%. The company had revenue of $273.76 million during the quarter, compared to analyst estimates of $273.58 million. During the same period in the prior year, the company earned ($0.15) earnings per share. The firm’s revenue was up .6% on a year-over-year basis. Research analysts expect that Moelis & Company will post 0.96 EPS for the current fiscal year.
Moelis & Company Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Monday, November 4th will be paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 3.16%. The ex-dividend date is Monday, November 4th. Moelis & Company’s payout ratio is presently 452.83%.
Moelis & Company Company Profile
Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.
Featured Articles
- Five stocks we like better than Moelis & Company
- Stock Market Upgrades: What Are They?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How Technical Indicators Can Help You Find Oversold StocksĀ
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Moelis & Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moelis & Company and related companies with MarketBeat.com's FREE daily email newsletter.